Key result
In vitro lipase inhibitors blunt heparin-induced NEFA elevations, suggesting drug binding changes are laboratory artifacts.
Why the study?
Does the in vitro addition of lipoprotein lipase inhibitors reduce heparin-induced alterations in protein drug binding in blood samples from healthy subjects?
Does the in vitro addition of lipoprotein lipase inhibitors reduce heparin-induced alterations in protein drug binding in blood samples from healthy subjects?
Answers are grounded in this paper and cite their sources.
Heparin-induced changes in protein drug binding are largely in vitro artifacts caused by continued triglyceride lipase activity.
Our purpose was to determine whether the reported alteration of protein drug binding after heparin administration in man was artifactual as a result of continued in vitro activity of triglyceride lipases. The lipoprotein lipase inhibitors protamine (14 mg/ml) and ethylenediaminetetraacetic acid (10 mg/ml) were added to blood samples from 11 healthy subjects before and 15 min after 100 USP units of intravenous heparin. Heparin elevated total nonesterified fatty acid (NEFA) concentration (P less than 0.001) and free fractions of lidocaine, diazepam, and propranolol (P less than 0.001 for all). The presence of the lipase inhibitors diminished the heparin-induced elevation of NEFA (P less than 0.001) and free fractions of lidocaine (P less than 0.001) and diazepam (P less than 0.001), but these values were still greater than control. The inhibitors reduced propranolol binding in control samples and did not diminish the effects of heparin. The change in NEFA concentrations correlated with the free fraction changes of all three ligands (r = 0.739 to 0.849). These data suggest that the heparin-induced protein binding changes are to, a large extent, in vitro artifacts.
No takes yet. Share an insight, caveat, or question.
Brown et al. (1981) studied Healthy subjects (n=11). Intravenous heparin and in vitro lipase inhibitors (protamine and EDTA) vs. Blood samples before heparin and without lipase inhibitors was evaluated on Change in nonesterified fatty acid (NEFA) concentration and free fractions of lidocaine, diazepam, and propranolol (p=<0.001). In vitro addition of lipase inhibitors diminished heparin-induced elevations of NEFA and free fractions of lidocaine and diazepam, suggesting these binding changes are largely in vitro artifacts.
Synapse has enriched 10 related papers. Consider them for comparative context: